Application of prodrugs to inflammatory diseases of the gut. - Wikidata - wikimedia - TriplyDB

Application of prodrugs to inflammatory diseases of the gut.

Application of prodrugs to inflammatory diseases of the gut.

http://www.wikidata.org/entity/Q37096512

about

Animal Models for Periodontal Disease Developing a metagenomic view of xenobiotic metabolism Chronic Inflammatory Diseases and Green Tea Polyphenols A novel murine model for chronic inflammatory alveolar bone loss.Maternal and congenital toxoplasmosis, currently available and novel therapies in horizon The macrophage pattern recognition scavenger receptors SR-A and CD36 protect against microbial induced pregnancy loss.GREEN TEA POLYPHENOLS MEDIATED APOPTOSIS IN INTESTINAL EPITHELIAL CELLS BY A FADD-DEPENDENT PATHWAY Green Tea Polyphenols and Sulfasalazine have Parallel Anti-Inflammatory Properties in Colitis Models The Diuretic Action of Weak and Strong Alcoholic Beverages in Elderly Men: A Randomized Diet-Controlled Crossover Trial.Beneficial effect of butyrate, Lactobacillus casei and L-carnitine combination in preference to each in experimental colitis.Nutrition intervention: a strategy against systemic inflammatory syndrome.Optimized prodrug approach: a means for achieving enhanced anti-inflammatory potential in experimentally induced colitis.Bumadizone calcium dihydrate microspheres compressed tablets for colon targeting: formulation, optimization and in vivo evaluation in rabbits.

P2860

Q27495941-B546F7CE-0719-46E6-9A79-3EC919CBD2DC Q28273307-C2947287-0226-458E-B4A9-7A4124E0D10F Q33851875-765CFC08-9306-40D8-9335-9A6193441B7F Q33862916-D1F6478A-87C4-4EE2-B01D-08430ABD1341 Q33943894-1DD8E75C-FBA4-4634-8E0E-302692F98C1C Q34030671-49E5FE7C-DA0B-43D1-82BB-8E5AC6E9A6C8 Q35047369-A58C1039-DFD4-45EB-9712-5FFDAAD555B6 Q36903569-D6E2D1FC-45DD-428A-8B27-B9923C237FBD Q41194910-FD07775F-67CE-44D3-8401-9AA69CDD241E Q41790367-62C8731B-8177-4158-ADDD-28ACE0A9A9A2 Q42703392-C4A5ED7F-54FD-4A20-ADCA-F74C45EDFA10 Q45951065-A029E9A4-0D5C-47D6-94BA-C3C4B6783CCD Q53604750-FA8B3A8A-A6C3-4743-9B26-1120B13FB643

P2860

Application of prodrugs to inflammatory diseases of the gut.

http://www.wikidata.org/entity/Q37096512

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 27 February 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Application of prodrugs to inflammatory diseases of the gut.

@en

Application of prodrugs to inflammatory diseases of the gut.

@nl

type

label

Application of prodrugs to inflammatory diseases of the gut.

@en

Application of prodrugs to inflammatory diseases of the gut.

@nl

prefLabel

Application of prodrugs to inflammatory diseases of the gut.

@en

Application of prodrugs to inflammatory diseases of the gut.

@nl

P1433

Q37096512-DEE4B551-3AE3-4E11-98A3-249C63BCE9B9

P1476

Q37096512-05CCF8FD-3679-44CA-BF57-21E5BBBB46FA

P2093

Q37096512-714F9F3C-2235-44BF-85E7-B39129F3BF28

Q37096512-AC8885FD-879F-4206-AE9B-3300B3230F20

P2860

Q37096512-073FCC23-6665-4631-A163-0D235AEA5817

Q37096512-084352B2-23E7-4EDF-BA9C-501FC57FBEF6

Q37096512-11285916-F340-4754-8FFB-FACBB8F8073E

Q37096512-1539D091-C9DA-44A8-A803-E1DC72DE42F8

Q37096512-174BE6BE-23C5-411A-B1FA-C4F897C2F121

Q37096512-1CBC6FFB-E045-439E-8323-ED2567410747

Q37096512-1D6854F5-C625-4AD4-9081-A6448990C797

Q37096512-21B5299E-DE12-43AB-928A-84BE6EE0192D

Q37096512-23CC80CA-E9B4-49FC-8654-6B5DCF0981BD

Q37096512-271C0669-1600-433F-8074-5555DD1093A4

P304

Q37096512-46E89389-F6FD-48F9-9808-DF587AFFE8CC

P31

Q37096512-F5DE3B11-4E27-45B7-BD65-7EAB0872E91B

P356

Q37096512-8C902E11-ADDD-4930-AA67-8E4E39357E99

P407

Q37096512-00480D20-C337-4297-B6F0-C0FBE43AFC3C

P433

Q37096512-CB7E07C5-A732-4338-B249-D332891CCA0D

P478

Q37096512-BEBAB58D-FB81-4F20-B8B1-DAD47F506D99

P577

Q37096512-728E315B-EC1A-4253-B855-6462B1F0DC7E

P5875

Q37096512-3CFD8FF8-0158-4830-931A-2B516B5E659F

P698

Q37096512-AAE298EC-12EC-4F3D-8B26-BD1116FFC5EC

P921

Q37096512-AEFB37E1-B0FF-4442-8B44-22A4510A1FE9

P932

Q37096512-74C04871-2C12-43F9-8481-11E79211D2CA

P356

MOLECULES13020452

P1433

P1476

Application of prodrugs to inflammatory diseases of the gut

@en

P2093

Helieh S Oz

http://www.w3.org/2001/XMLSchema#string

Jeffrey L Ebersole

http://www.w3.org/2001/XMLSchema#string

P2860

Oxidative Decay of DNA

Inflammatory Bowel Disease

Methionine derivatives diminish sulphide damage to colonocytes--implications for ulcerative colitis.

Methionine deficiency and hepatic injury in a dietary steatohepatitis model

Sulfasalazine: a potent and specific inhibitor of nuclear factor kappa B

Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene

S-adenosylmethionine synthesis: molecular mechanisms and clinical implications

Replenishment of glutathione levels improves mucosal function in experimental acute colitis.

Prevention of acetaminophen-induced liver toxicity by 2(R,S)-n-propylthiazolidine-4(R)-carboxylic acid in mice.

Mycophenolate mofetil reduces tissue damage and inflammation in an experimental model of colitis in rats.

P304

452-474

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3390/MOLECULES13020452

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P577

2008-02-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5547905

http://www.w3.org/2001/XMLSchema#string

P698

18305431

http://www.w3.org/2001/XMLSchema#string

P921

P932

6244946

http://www.w3.org/2001/XMLSchema#string